Amphastar pharmaceuticals aims to quadruple domestic manufacturing capacity at rancho cucamonga headquarters

Rancho cucamonga, ca / access newswire / july 14, 2025 / amphastar pharmaceuticals, inc. (nasdaq:amph), a bio-pharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, has announced a multi-year expansion of its u.s. manufacturing operations at its headquarters in rancho cucamonga, california. the company plans to quadruple its production capacity at this location over the next three to five years, reinforcing its commitment to domestic pharmaceutical manufacturing and strengthening supply chain resilience.
AMPH Ratings Summary
AMPH Quant Ranking